Inventor · disambiguated record
Jamal Temsamani
Also filed as: TEMSAMANI JAMAL
13 granted patents·6 pending applications·255 citations·filing 1994–2023
90Inventor score
Top patents by PatentIndex Score
19 records- 0194US5968909AMethod of modulating gene expression with reduced immunostimulatory responseHYBRIDON INC·Filed 1995·Granted Oct 19, 1999·148 cites·19 claims
- 0279US11712486B2Compositions and methods for cancer imaging and radiotherapyVECT HORUS·Filed 2018·Granted Aug 1, 2023·2 cites·9 claims
- 0377US7399747B1Peptides carrying substances across the blood brain barrierSYNT EM·Filed 1999·Granted Jul 15, 2008·59 cites·4 claims
- 0476US6667293B1Use of cyclodextrins to modulate gene expression with reduced immunostimulatory responseHYBRIDON INC·Filed 1995·Granted Dec 23, 2003·34 cites·9 claims
- 0574US12465660B2Compositions and methods for cancer imaging and radiotherapyVECT HORUS·Filed 2023·Granted Nov 11, 2025·0 cites·8 claims
- 0665US7365055B2Derivatives of morphine-6-glucuronide, pharmaceutical compositions containing them, their preparation method and their usesBTG INT LTD·Filed 2004·Granted Apr 29, 2008·6 cites·23 claims
- 0764US9192654B2Use of the PAT nanopeptide in treating and preventing neurodegenerative diseasesTEMSAMANI JAMAL·Filed 2011·Granted Nov 24, 2015·1 cites·5 claims
- 0860US9427455B2Use of the pat nanopeptide in the treatment of autoimmune diseasesTEMSAMANI JAMAL·Filed 2009·Granted Aug 30, 2016·0 cites·10 claims
- 0955US2023414780A1Transferrin receptor-binding molecules, conjugates thereof and their usesVECT HORUS·Filed 2023·Application pending·0 cites
- 1047US2005159360A1Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseasesSYNT EM A CORP OF FRANCE·Filed 2004·Application pending·0 cites
- 1145US7314626B2Use of peptide vectors to improve the immune response to antigensSYNT EM SA·Filed 2002·Granted Jan 1, 2008·0 cites·7 claims
- 1245US2006293242A1Transporting of taxoid derivatives through the blood brain barrierTEMSAMANI JAMAL·Filed 2002·Application pending·0 cites
- 1344US9468662B2Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseasesORPHIT·Filed 2015·Granted Oct 18, 2016·0 cites·11 claims
- 1441US2003148981A1Use of cyclodextrins to modulate gene expression with reduced immunostimulatory responseFiled 2002·Application pending·0 cites
- 1539US7527792B1Pharmaceutical composition comprising an anti-cancer and at least a peptideSYNT EM·Filed 1999·Granted May 5, 2009·4 cites·1 claims
- 1638US2007161553A1Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulationSYNT EM·Filed 2005·Application pending·0 cites
- 1737US2003186890A1Amphipathic linear peptides and formulations containing said peptidesSYNT EM SA·Filed 2003·Application pending·0 cites
- 1830US5693466ADetection of synthetic oligonucleotides extracted from body fluids or tissuesHYBRIDON INC·Filed 1995·Granted Dec 2, 1997·0 cites·12 claims
- 1930US5558992ADetection of synthetic oligonucleotides extracted from body fluids or tissuesHYBRIDON INC·Filed 1994·Granted Sep 24, 1996·1 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Jamal Temsamani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →